This article was originally published Jan. 8.

SAN FRANCISCO — Qiagen's CEO Peer Schatz said this week during a presentation at the JP Morgan Healthcare conference here that the company is on track to launch a clinically oriented next-gen sequencing system in the middle of this year.

Schatz added, however, that the platform is "simply a part of a complete solution" that involves leveraging Qiagen's broad array of tests, whether based on real-time PCR or sequencing, and "making that the complete solution for molecular diagnostics and biomedical research."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.